Verve Therapeutics Inc
VERV
Get informed when a big investor buys or sells
+ FollowMarket Cap$994.04M
Close$
$-9.37
184.2% downside
Current Fair Value
184.2% downsideOvervalued by 184.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $994.04 Million |
|---|---|
| Enterprise Value | $990.54 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.36 |
| Beta | 2.24 |
| Outstanding Shares | 88,796,000 |
Return
| Return on Equity | -38.23% |
|---|---|
| Return on Assets | -29.47% |
| Return on Invested Capital | -37.39% |
Valuation & Multiples
| P/E Ratio | -12.19 |
|---|---|
| PEG | 33.56 |
| Price to Sales | - |
| Price to Book Ratio | 2.23 |
| Enterprise Value to Revenue | 16.62 |
| Enterprise Value to EBIT | -4.71 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.2 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 6.5078▲ 619.12% |
|---|---|
| Total Calls | 448,600▲ 122.96% |
| Total Puts | 2,919,400▲ 4483.05% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 82.16%▼ 10.84% |
|---|---|
| Total Invested | $819.43M▲ 121.80% |
| Investors Holding | 186▼ 9.00% |
ESG Score
No data
About Verve Therapeutics Inc
63 employees